Hillsdale Investment Management Inc.
Position in BSX — Boston Scientific Corp
CIK 1368465
Toronto, A6
Position in BSX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$636,912
-$187,865 QoQ
Shares Held
10,150
+17.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $19,365,255 across 7 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
907,739 | $8,569,056 | |
| 2 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 3 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 4 | NVCR |
NovoCure Ltd
|
141,900 | $2,149,785 | |
| 5 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 6 | APYX |
Apyx Medical Corp
|
182,600 | $819,874 | |
| 7 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in BSX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $636,912 | 10,150 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $824,777 | 8,650 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $834,736 | 8,550 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $746,499 | 6,950 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $610,324 | 6,050 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $759,220 | 8,500 | Shares | Sole | 2025-02-11 | |
| 2023-09-30 | $549,120 | 10,400 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $470,583 | 8,700 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||